False-Susceptible Results from the MS-2 System Used for Testing Resistant Pseudomonas aeruginosa Against Two Third-Generation Cephalosporins, Moxalactam and Cefotaxime
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=271048Documentos Relacionados
- False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime.
- Attempted reduction of Abbott MS-2 false-susceptible errors for cefotaxime-resistant Pseudomonas aeruginosa by medium modification.
- In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.
- Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.
- False-positive results with third-generation monoclonal hepatitis B surface antigen enzyme immunoassay.